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1. Introduction 
The interaction of the components of adenylate 
cyclase (ATP pyrophosphate-lyase (cyclizing), EC 
4.6.1 .l)located at the inner face of plasma membranes 
is regulated, inter alia, by guanine nucleotides [l] and 
Mg2+ [2]. The role of guanine nucleotides has been 
extensively investigated with non-hydrolyzable 
analogues, by GTPase inhibition after cholera toxin 
pretreatment, and by solubilization and reconstitu- 
tion experiments [ 1,3,4]. 
effects of Mg2+ in rat heart and lung membranes. We 
conclude that the allosteric stimulatory role of Mg2+ 
is similar but variously expressed among mammalian 
tissues. 
2. Materials and methods 
Much less is known on the multiple role of Mg2+ 
apart from its contribution to the substrate ATP-Mg. 
Kinetics of adenylate cyclase activation are usually 
linear except upon exposure to non-hydrolyzable 
guanine nucleotide analogues for which a lag period 
in cyclic AMPaccumulation curve is generally observed. 
The modulation of this lag period by Mg’+, first 
described in rat reticulocytes [5], has been observed 
in other membranes including those from rat liver, 
S49 murine lymphoma cells, and rabbit corpus luteum 
[6,7]. These data, plus the Mg2+ requirement for per- 
sistent Gpp [NH] p activation of heart adenylate cyclase 
[8], and the blockade of Gpp[NH] p activation of liver 
adenylate cyclase by EDTA [9], allows to conclude 
that Mg2+ acts on an allosteric site in guanine nucleo- 
tide regulatory protein(s). 
Wistar albino male rats (200-250 g) with free 
access to standard food and water were sacrificed by 
decapitation. Heart and lungs were dissected out, 
rinsed at room temperature with isotonic NaCl, and 
minced with scissors. All subsequent operations were 
performed at 4°C. 
Our original finding that there is no lag period for 
Gpp [NH]p activation of rat cardiac adenylate cyclase 
under standard conditions with 5 mM Mg2+ [lO,l l] 
prompted us to further analyze and compare the 
A crude cardiac particulate fraction was prepared 
with minor modifications of the procedure in [ 121. 
The cardiac tissue was homogenized (5% (w/v) 
homogenate) in a 20 mM Tris-HCl, 2 mM dithioery- 
threitol, 5 mM MgC12 (pH 7.5) buffer. After filtration 
through 2 layers of medical gauze, the homogenate 
was centrifuged at 520 X g for 10 min. The pellet was 
washed once with the same buffer and resuspended in 
20 mM Tris-HCl, 0.25 M sucrose (pH 7.5) buffer. An 
equal volume of the same buffer enriched with 2.5 M 
KCl was added dropwise. The suspension was stirred 
continuously for 2 h at 4”C, then centrifuged at 
37 000 X g for 10 mm. The pellet was resuspended in 
a 20 mM Tris-HCl, 2 mM dithioerythreitol, 0.25 M 
sucrose (PH 7.5) buffer, washed 3 times in this buffer 
by centrifugation at 31 000 X g for 5 min and resus- 
pended in a volume of the same buffer allowing a final 
concentration of 6 mg protein/ml. 
Abbreviation: Gpp[ NH]p, guanosine S’-@,y-imido)triphos- 
phate 
* To whom correspondence should be addressed 
Lungs were homogenized (5% (w/v) homogenate) 
in a 20 mM Tris-HCl, 2 mM dithioerythreitol, 0.25 M 
sucrose (PH 7.5) buffer. After filtration through 2 
layers of medical gauze, the homogenate was centri- 
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fuged at 31 000 X g for 10 min. The pellet was 
resuspended in the same buffer at 10 mg protein/ml 
final cont. 
Adenylate cyclase activity was determined by the 
conversion of [cY-~~P] ATP into cyclic [32P] AMP [ 131. 
The assay medium contained the following final con- 
centrations: 0.5 mM [a+“P]ATP, 0.5 mM EGTA, 
1 mM cyclic AMP, 1 mM theophylline, 30 mM Tris- 
HCl, and an ATP-regenerating system which consisted 
of 10 mM phospho(enol)pyruvate and pyruvate kinase 
(30 I.cg/ml). The pH was adjusted to 7.4. The kinetics 
of adenylate cyclase activity were determined as fol- 
lows: each glass tube contained 0.60 ml standard assay 
medium equilibrated at 37°C. The incubation was 
initiated by adding 0.12 ml of the membrane suspen- 
sion equilibrated at the desired [Mg2+]. At fixed inter- 
vals (1 or 2 min), 0.05 ml aliquots of the incubation 
medium were removed and added to 0.50 ml of a 
0.5% SDS solution containing 1.5 mM ATP, 0.5 mM 
cyclic AMP and cyclic [ ?v~H] AMP (20 000 cpm to 
determine nucleotide recovery). Cyclic AMP was sepa- 
rated from ATP by 2 successive chromatographies on 
Dowex AGI X 8 and neutral alumina [ 131. 
Phospho(enol)pyruvate, pyruvate kinase, ATP 
(sodium salt, grade I). GTP, cyclic AMP, and D,L-iso- 
proterenol were purchased from Sigma Chemical Co. 
(St Louis, MO). Gpp[NH]p was obtained from 
Boehringer (Mamrheim). Cyclic [ 8-3H] AMP and 
[cv-~~P] ATP, obtained from the Radiochemical Centre 
(Amersham, Bucks), had spec. act. 27 Ci/mmol and 
1 O-20 Ci/mmol, respectively. 
3. Results 
In the presence of a maximally activating Gpp [NH] p 
concentration, the rate of cyclic AMP production in 
both heart (fig.1) and lung (fig.2) membranes depended 
on [Mg2’]. At a low (0.5 mM) Mg2+ concentration, a 
lag period was obvious. When the divalent ion concen- 
tration was progressively increased above ATP con- 
centration, the lag period decreased and the enzyme 
activity increased. In heart, the rate of activation was 
both maximal and linear at 4 mM Mg2+ (fig.1) so that 
higher Mg2+ levels (at 6 mM (fig.l), 8 mM, 20 mM 
and 30 mM (not shown)) exerted no added effect. 
The low basal activities in the absence of Gpp [NH] p 
were linear at all [Mg’+] tested (not shown). 
The effects observed on lung adenylate cyclase 
activity with increasing [Mg’+] (fig.2) were qualita- 
tively similar but the lung enzyme was less sensitive 
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Fig.1. Dependence on [Mg’+] of the time course of activation 
of rat cardiac adenylate cyclase by 1O-4 M Gpp[NH]p; Mg2+ 
levels indicated were the total [Mg’+] in the incubation 
medium. For medium composition and incubation conditions, 
see section 2. The apparent lag period is obtained by extrapo- 
lation (---). This experiment was representative of 4 others. 
to Mg2+ than the heart system. At any given [Mg’+] 
the lag period was, indeed, more important in lung 
than in heart membranes (the lag period at 0.5 mM 
Mg*+ in lung was, for instance, twice the lag period in 
heart). At 4-6 mM Mg2+, that are commonly used in 
adenylate cyclase assays, the lag period was still 
apparent in lung while the rate of activation was linear 
in heart. 
As shown in fig.3,4, lag periods were also observed 
at 0.5 mM Mg*+ when adenylate cyclase activity was 
stimulated by NaF in heart and lung membranes, and 
by GTP in lung membranes. (No significant activation 
by GTP could be observed in heart as in [10,14].) 
With NaF activation, increasing the [Mg*+] increased 
the enzyme activity and linearized the formation of 
cyclic AMP as a function of time (Bg.3,4). Finally, 
0.1 mM D,Lisoproterenol was also able to linearize 
the time course of Gpp [NH] p activation at all Mg2+ 
levels (tig.3,4, not shown). 
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Fig.2. Dependence on [Mg’+] of the time course of activation 
of rat lung adenylate cyclase by 10s4 M Gpp[NH]p. For 
details, see legend for fii. 1. This experiment was representative 
of 4 others. 
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Fig.4. Time course of activation of rat lung adenylate cyclase 
by 1O-4 M GTP (x), lo-’ M Gpp[NH]p (o), lo-’ M 
Gpp[NH]p + 10e4 M D,L-isoproterenol (o), and 10-a M NaF 
(0,~). Mga+ levels refer to total [Mg’+] in the incubation 
medium. For details, see legend for fii.1. This experiment 
was representative of 4 others. 
Fig.3. Time course of activation of rat cardiac adenylate 
cyclase by 10e4 M GTP (X), lo-* M Gpp[NH]p (o), 10e4 M 
Gpp [ NH] p + 10s4 M D,L-isoproterenol (a), and 10-a M NaF 
(n,=). Mga+ levels refer to total [Mga+] concentrations in the 
incubation medium. For details, see legend for fgl. This 
experiment was representative of 4 others. 
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4. Discussion 
In line with results on membranes from rat liver, 
S49 murine lymphoma cells, and rabbit corpus luteum 
[6,7], these data showed that the lag period of adenyl- 
ate cyclase activation by Gpp [NH]p was modulated 
by [Mg2+] in both heart and lung membranes from 
rat. This indicates that a lag period for Gpp [NH] p 
activation is a general phenomenon in mammalian 
adenylate cyclase systems and contrasts with the situ- 
ation in turkey erythrocyte where Mg2+ is unable to 
modify this parameter [6]. 
Quantitative differences were obvious when com- 
paring heart and lung membranes (fig.l,2), that were 
not due to the mode of preparation of rat cardiac 
membranes, as identical results were obtained with a 
crude particulate heart fraction untreated with KCl. 
These differences might, conceivably, reflect distinct 
intrinsic properties of the guanine nucleotide regulatory 
protein(s) or the presence of other controlling factor(s) 
such as the lipidic environment. 
Of particular interest was the fact that a lag period 
was observed, at 0.5 mM Mg2+, with GTP activation 
in lung membranes (fig.4) and also with NaF activa- 
tion in both heart and lung membranes (fig.3,4). This 
confirms [6,7] that the lag period depends on several 
factors, including the chemical nature of the nucleo- 
tide activator and a stimulatory effect of Mg2+ on the 
activation of guanine nucleotide regulatory protein(s). 
In the presence of D,Lisoproterenol and 
Gpp [NH] p, the time course of cyclic AMP forma- 
tion waslinear at all [Mg’+] tested (fig.3,4, not shown). 
At least two explanations may account for the dis- 
appearance of the lag period due to D,L-isoproterenol: 
(1) 
(2) 
The time period required for endogenous nucleo- 
tides to dissociate from guanine nucleotide regu- 
latory protein(s) may be responsible for the lag 
period; its shortening could result from the D,L 
isoproterenol-stimulated release and/or exchange 
of endogenous nucleotides [ 15,161; 
The lag period might be due to a slow isomeriza- 
tion between two activity states of the system 
with the hormone increasing the rate of isomeri- 
zation to the active state [ 17,l S]. 
Conceivably, a hormone and Mg’+, when used in com- 
bination, may simply exert additive effects on the 
reduction of the lag period; alternatively, the accel- 
eration of the isomerization process induced by the 
hormone may decrease the allosteric Mg2+ require- 
ments. 
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